ATC Abstracts

American Transplant Congress abstracts

2015 American Transplant Congress

May 2-6, 2015 in Philadelphia, Pennsylvania

View by Title View Sessions
View by Date

Tuesday, May 5, 2015

5:30pm-6:30pm
Pharmacokinetics of Tacrolimus (TAC) in Elderly Compared to Young Recipients in the First Year After Renal Transplantation. Data from the NEverOLd Trial

E. David-Neto,1 P. Romano,2 A. Triboni,1 F. Agena,1 P. Ebner,2 F. Ramos,1 N. Galante,1 F. Lemos.1

Poster Session D: Kidney Immunosuppression: Drug Minimization  •  Exhibit Hall E
5:30pm-6:30pm
Phenotype of Renal Tubular Cell Death During Delayed Graft Function

S. Jain,1 R. Plenter,1 T. Nydam,1 C. Ruller,1 C. Edelstein,1,2 A. Jani.1,2

Poster Session D: Innate Immunity in Transplantation  •  Exhibit Hall E
5:30pm-6:30pm
Plasma 4β-Hydroxycholesterol Measurement as a Potential Biomarker for CYP3A5 Activity in Informing Tacrolimus Dosing

T. Elnahhas,1,2 E. de Jonge,4 T. Lee,2 B. van Zelst,4 J. Popoola,3 R. Ramkhelawon,3 R. van Schaik,4 A. Johnston,1,2 I. MacPhee.3

Poster Session D: Kidney Immunosuppression: Drug Minimization  •  Exhibit Hall E
5:30pm-6:30pm
Plasma Cell Infiltration: General Overview of Clinical and Pathological Correlations in Renal Transplantation

C. Nihei, F. Lemos, D. David, P. Souza, F. de Paula, W. Nahas, E. David-Neto.

Poster Session D: Kidney: Acute Rejection  •  Exhibit Hall E
5:30pm-6:30pm
Post Hoc Subgroup Analysis of ZEUS: Outcome on Renal Function, Efficacy and Safety in Living-Donor Kidney Transplant Recipients After Conversion from a Calcineurin Inhibitor to an Everolimus Based Regimen: 5 Year Follow-Up Data

F. Lehner,1 K. Budde,1 R. Wuethrich,2 P. Reinke,1 W. Arns,1 A. Muehlfeld,1 U. Eisenberger,1 R. Stahl,1 K. Heller,1 O. Witzke,1 B. Suwelack,1 H. Wolters,1 I. Hauser,1 M. Porstner,3 C. Sommerer.1

Poster Session D: Kidney Immunosuppression: Drug Minimization  •  Exhibit Hall E
5:30pm-6:30pm
Pre-Trasplant Perfusion With Mesenchymal Stromal Cells of Renal Graft Prevents Ischemia Injury Upregulating Gene Involved in Energy Saving

V. Corradetti,1 S. Milanesi,1 E. Pattonieri,1 C. Rocca,1 T. Valsania,1 M. Gregorini,1 L. De Cecco,2 I. Benzoni,3 C. Bianco,3 M. Avanzini,4 M. Maestri,3 P. Esposito,1 T. Rampino,1 A. Dal Canton.

Poster Session D: Late Breaking  •  Exhibit Hall E
5:30pm-6:30pm
Preemptive Rituximab Therapy of Epstein-Barr Virus (EBV) Infection to Prevent Post-Transplant Lymphoproliferative Disease (PTLD) After Pediatric Solid Organ Transplantation (SOT)

Y. Ahn,1 N.-J. Yi,2 S. Min,2 I.-S. Ha,1 H. Cheong,1 H. Kang.1

Poster Session D: Pediatric Clinical Kidney Transplantation  •  Exhibit Hall E
5:30pm-6:30pm
Preemptive Therapy for Cytomegalovirus Disease in Liver Transplant Recipients-A Single Center Experience

N. Alvey,1 J. Tieman,1 A. Diamond,2 A. Hodowanec,1 D. Simon,1 S. Fayek,1 M. Hertl,1 O. Olaitan,1 E. Hollinger,1 E. Chan.1

Poster Session D: Viral Infections  •  Exhibit Hall E
5:30pm-6:30pm
Preferences for Policy Options for Deceased Organ Donation for Transplantation: A Discrete Choice Experiment

K. Howard,1 S. Jan,2 J. Rose,3 G. Wong,1,4 J. Craig,1,4 M. Irving,1 A. Tong,1,4 S. Chadban,1,5 R. Allen,5 A. Cass.6

Poster Session D: Regulatory Issues in Transplant Administration  •  Exhibit Hall E
5:30pm-6:30pm
Preformed IgA Antibodies to B2-Glycoprotein Is an Indepedent Risk Factor for Graft Thrombosis and Early Graft Loss After Renal Transplantation

J. Morales,1 M. Serrano,3 J. Martinez,2 D. Perez,2 M. Sevilla,2 A. Amdres,3 E. Gonzalez,3 E. Paz-Artal,2 A. Serrano.2

Poster Session D: Donor Specific Antibodies/Antibody Mediated Rejection  •  Exhibit Hall E